American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$374M |
| 2 |
Meta Platforms (Facebook)
META
|
+$255M |
| 3 |
Salesforce
CRM
|
+$200M |
| 4 |
Target
TGT
|
+$132M |
| 5 |
Reinsurance Group of America
RGA
|
+$124M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$322M |
| 2 |
Visa
V
|
+$240M |
| 3 |
T-Mobile US
TMUS
|
+$229M |
| 4 |
MSCI
MSCI
|
+$209M |
| 5 |
IQVIA
IQV
|
+$209M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.34% |
| 2 | Healthcare | 13.84% |
| 3 | Financials | 13.35% |
| 4 | Consumer Discretionary | 11.5% |
| 5 | Industrials | 10.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2676
Cue Biopharma
CUE
$119M
| $44K | ﹤0.01% |
+402
| New | +$47.2K |
|
2677
Oramed Pharmaceuticals
ORMP
$182M
| $42.2K | ﹤0.01% |
+11,789
| New | +$37.8K |
|
2678
Adicet Bio
ACET
$78.4M
| $41.2K | ﹤0.01% |
1,059
+420
| +66% | +$37.1K |
|
|
NGM
2679
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $40.8K | ﹤0.01% |
+15,738
| New | +$56.1K |
|
2680
Latham Group
SWIM
$907M
| $40.7K | ﹤0.01% |
+10,982
| New | +$33.6K |
|
2681
Altimmune
ALT
$574M
| $39.4K | ﹤0.01% |
+11,171
| New | +$50.2K |
|
|
ATYR
2682
aTyr Pharma
ATYR
$56.1M
| $30.7K | ﹤0.01% |
+14,191
| New | +$31K |
|
2683
Nkarta
NKTX
$173M
| $29.9K | ﹤0.01% |
+13,640
| New | +$60K |
|
2684
Telos
TLS
$330M
| $28.5K | ﹤0.01% |
+11,149
| New | +$26.4K |
|
|
AGEN
2685
Agenus
AGEN
$315M
| $27.3K | ﹤0.01% |
853
-16
| -2% | -$512 |
|
2686
Arbutus Biopharma
ABUS
$908M
| $24.5K | ﹤0.01% |
+10,660
| New | +$27.7K |
|
2687
Atara Biotherapeutics
ATRA
$79.9M
| $23.6K | ﹤0.01% |
585
-320
| -35% | -$18.1K |
|
|
GAU
2688
Galiano Gold
GAU
$549M
| $22.9K | ﹤0.01% |
37,966
| – | – |
|
|
TDAY
2689
USA Today Co
TDAY
$1.02B
| $22.8K | ﹤0.01% |
+10,153
| New | +$20.3K |
|
|
TSP
2690
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
| $22.2K | ﹤0.01% |
13,350
-666
| -5% | -$1.08K |
|
|
PSTX
2691
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $22K | ﹤0.01% |
12,477
+22
| +0.2% | +$56 |
|
|
CODX
2692
Co-Diagnostics
CODX
$5.64M
| $12.6K | ﹤0.01% |
380
-6,993
| -95% | -$268K |
|
|
CANG
2693
Cango Inc
CANG
$93.9M
| $11.9K | ﹤0.01% |
1,019
| – | – |
|
|
AEVA
2694
Aeva Technologies
AEVA
$1.78B
| – | – |
-4,188
| Closed | -$23.5K |
|
2695
Acadia Realty Trust
AKR
$2.86B
| – | – |
-19,449
| Closed | -$271K |
|
|
ALLK
2696
DELISTED
Allakos
ALLK
| – | – |
-20,106
| Closed | -$86.5K |
|
2697
Ardelyx
ARDX
$1.01B
| – | – |
-15,475
| Closed | -$71K |
|
2698
Algoma Steel
ASTL
$472M
| – | – |
-228,692
| Closed | -$1.76M |
|
2699
Black Hills Corp
BKH
$5.65B
| – | – |
-112,071
| Closed | -$7.07M |
|
2700
Barnes & Noble Education
BNED
$426M
| – | – |
-198
| Closed | -$30.6K |
|
Similar funds
American Century Companies's Q2 2023 Portfolio in Review
As of Q2 2023, American Century Companies held 2,884 positions worth $133B, up 4.5% from $127B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
American Century Companies's Q2 2023 filing shows 216 new, 1,601 increased, 807 reduced and 96 closed positions. Its largest new stake was Kenvue: 2,518,495 shares worth $66.5M. The largest sale was Microsoft, an estimated $322M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- American Century Companies's largest Q2 2023 buy was Kenvue: 2,518,495 shares worth $66.5M.
- American Century Companies added most to Becton Dickinson in Q2 2023, an estimated $374M increase.
- American Century Companies's biggest Q2 2023 reduction was Microsoft, cutting an estimated $322M.
- American Century Companies fully exited Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6.00% Mandatory Convertible Preferred Stock, Series B in Q2 2023, selling an estimated $199M.
- American Century Companies's ten largest holdings make up 22% of its $133B portfolio in Q2 2023.
- American Century Companies opened 216 new positions and closed 96 in Q2 2023.
- American Century Companies's portfolio value rose 4.5% quarter-over-quarter to $133B.
Based on American Century Companies's 13F filing for Q2 2023, filed 14 Aug 2023.